Want to see BIAF full AI Analyst Report?
bioAffinity Technologies, Inc. (BIAF) Ratios
bioAffinity Technologies, Inc. Ratios
BIAF's free cash flow for Q2 2026 was $-3.29M. For the 2026 fiscal year, BIAF's free cash flow was decreased by $-89.97K and operating cash flow was $-3.20M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.60 | 0.87 | 1.77 | 10.50 | 0.11 |
| Quick Ratio | 2.58 | 0.86 | 1.76 | 10.50 | 0.11 |
| Cash Ratio | 2.22 | 0.36 | 1.26 | 10.02 | 0.10 |
| Solvency Ratio | -3.91 | -2.16 | -2.28 | -7.15 | -0.37 |
| Operating Cash Flow Ratio | -3.21 | -2.34 | -2.69 | -3.58 | -0.16 |
| Short-Term Operating Cash Flow Coverage | -24.30 | -42.32 | 0.00 | -16.17 | -0.18 |
| Net Current Asset Value | $ 3.88M | $ -1.22M | $ 606.45K | $ 10.82M | $ -15.81M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.23 | 0.19 | 0.02 | 7.82 |
| Debt-to-Equity Ratio | 0.16 | 0.58 | 0.33 | 0.02 | -0.72 |
| Debt-to-Capital Ratio | 0.14 | 0.37 | 0.25 | 0.02 | -2.57 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.01 | 0.00 | 0.00 | -0.01 |
| Financial Leverage Ratio | 1.51 | 2.50 | 1.69 | 1.10 | -0.09 |
| Debt Service Coverage Ratio | -33.53 | -31.58 | -206.06 | -2.02 | -0.44 |
| Interest Coverage Ratio | -238.27 | -96.82 | -214.76 | -1.58 | -2.20 |
| Debt to Market Cap | 0.21 | 0.02 | 0.00 | 0.03 | 0.19 |
| Interest Debt Per Share | 10.50 | 3.94 | 5.54 | 18.57 | 50.28 |
| Net Debt to EBITDA | 0.37 | -0.05 | 0.16 | 1.99 | -1.88 |
| Profitability Margins | |||||
| Gross Profit Margin | 23.21% | 36.09% | 31.26% | 90.28% | 0.00% |
| EBIT Margin | -240.53% | -95.45% | -311.18% | -116989.67% | 0.00% |
| EBITDA Margin | -232.34% | -88.98% | -301.30% | -116777.68% | 0.00% |
| Operating Profit Margin | -171.58% | -95.63% | -314.89% | -83511.51% | 0.00% |
| Pretax Profit Margin | -241.25% | -96.44% | -312.64% | -169720.05% | 0.00% |
| Net Profit Margin | -241.96% | -96.56% | -313.47% | -169771.25% | 0.00% |
| Continuous Operations Profit Margin | -241.96% | -96.56% | -313.47% | -169771.25% | 0.00% |
| Net Income Per EBT | 100.30% | 100.13% | 100.27% | 100.03% | 100.03% |
| EBT Per EBIT | 140.61% | 100.84% | 99.29% | 203.23% | 286.59% |
| Return on Assets (ROA) | -136.03% | -138.79% | -96.54% | -66.94% | -435.31% |
| Return on Equity (ROE) | -204.87% | -347.42% | -163.47% | -73.84% | 40.06% |
| Return on Capital Employed (ROCE) | -131.26% | -262.65% | -133.47% | -36.32% | 19.05% |
| Return on Invested Capital (ROIC) | -125.29% | -218.19% | -123.92% | -35.51% | 577.71% |
| Return on Tangible Assets | -168.67% | -208.58% | -132.65% | -66.94% | -435.31% |
| Earnings Yield | -734.15% | -81.90% | -61.72% | -113.28% | -10.33% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.37 | 8.22 | 3.12 | 0.46 | 0.00 |
| Payables Turnover | 6.21 | 6.06 | 2.88 | 0.00 | 0.02 |
| Inventory Turnover | 88.36 | 216.71 | 94.19 | 0.08 | 0.00 |
| Fixed Asset Turnover | 4.88 | 5.78 | 1.27 | 0.02 | 0.00 |
| Asset Turnover | 0.56 | 1.44 | 0.31 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 2.90 | 14.24 | 0.40 | -0.01 | 0.00 |
| Cash Conversion Cycle | -22.54 | -14.13 | -5.91 | -264552.43 | -17458.70 |
| Days of Sales Outstanding | 32.10 | 44.41 | 117.01 | 797.10 | 0.00 |
| Days of Inventory Outstanding | 4.13 | 1.68 | 3.88 | 4329.98 | 0.00 |
| Days of Payables Outstanding | 58.77 | 60.23 | 126.79 | 269679.51 | 17458.70 |
| Operating Cycle | 36.23 | 46.10 | 120.88 | 5127.08 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -81.30 | -17.97 | -20.71 | -27.14 | -8.33 |
| Free Cash Flow Per Share | -81.83 | -18.16 | -20.78 | -28.61 | -8.33 |
| Dividend Paid and CapEx Coverage Ratio | -154.02 | -91.86 | -263.64 | -18.50 | 0.00 |
| Capital Expenditure Coverage Ratio | -154.02 | -91.86 | -263.64 | -18.50 | 0.00 |
| Operating Cash Flow Coverage Ratio | -8.04 | -4.84 | -3.82 | -16.17 | -0.18 |
| Operating Cash Flow to Sales Ratio | -1.51 | -0.78 | -2.38 | -847.56 | 0.00 |
| Free Cash Flow Yield | -462.33% | -66.53% | -47.13% | -59.61% | -3.35% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.14 | -1.21 | -1.62 | -0.88 | -9.68 |
| Price-to-Sales (P/S) Ratio | 0.33 | 1.18 | 5.08 | 1498.73 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.28 | 4.24 | 2.65 | 0.65 | -3.88 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.22 | -1.50 | -2.12 | -1.68 | -29.89 |
| Price-to-Operating Cash Flow Ratio | -0.22 | -1.52 | -2.13 | -1.77 | -29.89 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.07 | 0.03 | -0.01 | 0.74 |
| Enterprise Value Multiple | 0.23 | -1.37 | -1.52 | 0.71 | -13.40 |
| Enterprise Value | -3.26M | 11.43M | 11.62M | -3.96M | 71.24M |
| EV to EBITDA | 0.23 | -1.37 | -1.52 | 0.71 | -13.40 |
| EV to Sales | -0.53 | 1.22 | 4.59 | -825.23 | 0.00 |
| EV to Free Cash Flow | 0.35 | -1.56 | -1.92 | 0.92 | -34.77 |
| EV to Operating Cash Flow | 0.35 | -1.57 | -1.92 | 0.97 | -34.77 |
| Tangible Book Value Per Share | 44.94 | 1.04 | 8.98 | 73.64 | -64.21 |
| Shareholders’ Equity Per Share | 63.43 | 6.44 | 16.65 | 73.64 | -64.21 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 53.70 | 23.15 | 8.68 | 0.03 | 0.00 |
| Net Income Per Share | -129.94 | -22.36 | -27.22 | -54.37 | -25.72 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.01 | 1.00 | 1.45 | 1.19 |
| Research & Development to Revenue | 0.34 | 0.19 | 0.68 | 317.34 | 0.00 |
| SG&A to Revenue | 1.61 | 1.06 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.11 | 0.11 | 0.30 | 51.76 | 0.00 |
| Income Quality | 0.63 | 0.80 | 0.76 | 0.50 | 0.32 |
Currency in USD